Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
Authors:
- Habib BashourHBHabib Bashour
- Eva SmorodinaESEva Smorodina
- Matteo ParisetMPMatteo Pariset
- Jahn ZhongJZJahn Zhong
- Rahmad AkbarRARahmad Akbar
- Maria ChernigovskayaMCMaria Chernigovskaya
- Khang Lê QuýKQKhang Lê Quý
- Igor SnapkovISIgor Snapkov
- Puneet RawatPuneet Rawat
- Konrad KrawczykKKKonrad Krawczyk
- Geir Kjetil SandveGSGeir Kjetil Sandve
- Jose Gutierrez-MarcosJGJose Gutierrez-Marcos
Preprint
Abstract
Designing effective monoclonal antibody (mAb) therapeutics faces a multi-parameter optimization challenge known as “developability”, which reflects an antibody’s ability to progress through development stages based on its physicochemical properties. While natural antibodies may provide valuable guidance for mAb selection, we lack a comprehensive understanding of natural developability parameter (DP) plasticity (redundancy, predictability, sensitivity) and how the DP landscapes of human-engineered and natural antibodies relate to one another. These gaps hinder fundamental developability profile cartography. To chart natural and engineered DP landscapes, we computed 40 sequence- and 46 structure-based DPs of over two million native and human-engineered single-chain antibody sequences. We found lower redundancy among structure-based compared to sequence-based DPs. Sequence DP sensitivity to single amino acid substitutions varied by antibody region and DP, and structure DP values varied across the conformational ensemble of antibody structures. Sequence DPs were more predictable than structure-based ones across different machine-learning tasks and embeddings, indicating a constrained sequence-based design space. Human-engineered antibodies were localized within the developability and sequence landscapes of natural antibodies, suggesting that human-engineered antibodies explore mere subspaces of the natural one. Our work quantifies the plasticity of antibody developability, providing a fundamental resource for multi-parameter therapeutic mAb design.Keywords
All Related Versions
- Published version: Communications Biology, 7 (1), 1.
This publication has 197 references indexed in Scilit:
- Is an Intuitive Convergence Definition of Molecular Dynamics Simulations Solely Based on the Root Mean Square Deviation Possible?Journal of Computational Biology, 2011
- ProDy: Protein Dynamics Inferred from Theory and ExperimentsBioinformatics, 2011
- Multiple imputation by chained equations: what is it and how does it work?International Journal of Methods in Psychiatric Research, 2011
- Search and clustering orders of magnitude faster than BLASTBioinformatics, 2010
- Improved side‐chain torsion potentials for the Amber ff99SB protein force fieldProteins: Structure, Function, and Bioinformatics, 2010
- PyRosetta: a script-based interface for implementing molecular modeling algorithms using RosettaBioinformatics, 2010
- Canonical sampling through velocity rescalingThe Journal of Chemical Physics, 2007
- How to measure and predict the molar absorption coefficient of a proteinProtein Science, 1995
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983